スーパーコピー グッチコピー ブランドコピー スーパーコピー通販 ブランド偽物 スーパーコピー通販
Products | Reliatech CoupTFII/NR2F2 :: ReliaTech WebShop

Shopping Cart

You have 0 items in your cart
    You are currently here:

    Rabbit Anti-Human CoupTFII/NR2F2 NEW

    Size:
    p.i.
    Price:
    p.i. 0
    Formulation:
    Polyclonal Antibody ; lyophilized
    Catalog Number:
    102-PA17
    Synonyms:
    COUP-TF2, Apolipoprotein A-I regulatory protein 1, ARP-1, COUP transcription factor II, COUP-TF II, Nuclear receptor subfamily 2 group F member 2
    Stability:
    The lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C.
    Reconstitution:
    Reconstitute in sterile water to a concentration of 0.1-1.0mg/mL.
    Description:
    Tumor growth depends on nutrients and oxygen supplied by the vasculature through angiogenesis. It was shown that the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), a member of the nuclear receptor family, is a major angiogenesis regulator within the tumor microenvironment. COUP-TFs consist of two highly homologous subtypes, COUP-TFI (EAR-3, NR2F1) and COUP-TFII (ARP-1, NR2F2). Conditional ablation of COUP-TFII in the tumor microenvironment severely compromised neoangiogenesis and lymphangiogenesis during pancreatic tumor progression and metastasis. It was shown that COUP-TFII plays a cell-autonomous role in endothelial cells to control blood vessel sprouting by regulating cell proliferation and migration. Mechanistic investigations revealed that COUP-TFII suppressed vascular endothelial growth factor receptor-2 (VEGFR-2/KDR) signaling by transcriptionally repressing the expression of VEGFR-1, thereby curtailing a central angiogenic driver of vascular growth. These results implicate COUP-TFII as a critical factor in tumor angiogenesis through regulation of VEGF/VEGFR-2 signaling, suggesting COUP-TFII as a candidate target for antiangiogenic therapy.
    NCBI Gene ID:
    7026
    Uniprot:
    P24468